about
Premonitory Symptoms of Migraine in Childhood and Adolescence.Side effects associated with current and prospective antimigraine pharmacotherapies.The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine.Acute treatment of migraine: quo vadis?Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential.Targeted 5-HT1F Therapies for Migraine.Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice
P2860
Q38667059-D95EC55F-B03D-4B09-841F-EA60788F2010Q47309054-20D708B7-810D-4850-A1EE-96FDD9BD0306Q48021540-4AC72EB0-92A6-4B5F-A6D4-F81EA1EC3390Q48131347-C8530DAB-755E-4990-BF50-509BE53A529AQ52643768-C58446BF-3CC5-4737-8D95-772A8AEF9317Q52682101-5746FE8B-B628-4E30-94E8-FD339DB3E147Q57481750-9FC63F5E-7133-4D95-B544-FFDEBE756D64
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Lasmiditan for the treatment of migraine.
@en
type
label
Lasmiditan for the treatment of migraine.
@en
prefLabel
Lasmiditan for the treatment of migraine.
@en
P2093
P2860
P50
P1476
Lasmiditan for the treatment of migraine.
@en
P2093
Fabiola Cipolla
Luana Lionetto
Marina Borro
Matilde Capi
P2860
P304
P356
10.1080/13543784.2017.1280457
P407
P577
2017-01-11T00:00:00Z